HPV-associated genital diseases: current diagnosis and treatment options

HPV-associated genital diseases: current diagnosis and treatment options

Optimizing the management of patients with HPV-associated cervical diseases remains a priority for the modern studies on this issue. The human papillomavirus is divided into two types: high-risk and low-risk types according to its malignant potential to cause cervical cancer and some other oncologic...

Full description

Bibliographic Details
Main Authors:	E. R. Dovletkhanova, P. R. Abakarova
Format:	Article
Language:	Russian
Published:	Remedium Group LLC 2020-04-01
Series:	Медицинский совет
Subjects:	human papillomavirus infection cervicovaginal fluid biomarkers hpv persistence methylation hpv-associated diseases
Online Access:	https://www.med-sovet.pro/jour/article/view/5578

Similar Items

Biomarkers of cervicovaginal fluid for the diagnosis of cervical diseases associated with human papilloma virus (literature review)
by: Vera N. Prilepskaya, et al.
Published: (2020-04-01)

Measuring vaccine effectiveness against persistent HPV infections: a comparison of different statistical approaches
by: R. Donken, et al.
Published: (2020-07-01)

The possibility of using antiviral drugs with immunomodulatory effects in treating HPV-associated diseases
by: El R Dovletkhanova, et al.
Published: (2014-10-01)

Epidemiology and Burden of Human Papillomavirus and Related Diseases, Molecular Pathogenesis, and Vaccine Evaluation
by: Arnaud John Kombe Kombe, et al.
Published: (2021-01-01)

Assessment of the State of Knowledge about HPV Infection and HPV Vaccination among Polish Resident Doctors
by: Katarzyna Smolarczyk, et al.
Published: (2021-01-01)

High prevalence of co-infection between human papillomavirus (HPV) 51 and 52 in Mexican population
by: Jazbet Gallegos-Bolaños, et al.
Published: (2017-08-01)

Multiple HPV Infections and Viral Load Association in Persistent Cervical Lesions in Mexican Women
by: Mariel A. Oyervides-Muñoz, et al.
Published: (2020-03-01)

Ten years of anti-HPV vaccinations: what do we know?
by: Robert Jach, et al.
Published: (2016-11-01)

Maternal human papillomavirus infections at mid-pregnancy and delivery in a Scandinavian mother–child cohort study
by: Magdalena R. Værnesbranden, et al.
Published: (2021-07-01)

Determinants of non-uptake of the quadrivalent HPV vaccine; The Ontario Grade 8 HPV Vaccine Cohort Study
by: Remes, OLIVIA
Published: (2013)

HPV Population Profiling in Healthy Men by Next-Generation Deep Sequencing Coupled with HPV-QUEST
by: Li Yin, et al.
Published: (2016-01-01)

Methylation of CpG 5962 in L1 of the human papillomavirus 16 genome as a potential predictive marker for viral persistence: A prospective large cohort study using cervical swab samples
by: Jasmin Fertey, et al.
Published: (2020-02-01)

Prevalence and genotype distribution of HPV infection among 214,715 women from Southern China, 2012–2018: baseline measures prior to mass HPV vaccination
by: Li-pei Luo, et al.
Published: (2021-04-01)

Self-collected vaginal sampling for the detection of genital human papillomavirus (HPV) using careHPV among Ghanaian women
by: Dorcas Obiri-Yeboah, et al.
Published: (2017-09-01)

The specifities of the HPV-genital infections in males
by: Mihael Skerlev, et al.
Published: (2010-08-01)

Alpha, Beta, gamma human PapillomaViruses (HPV) detection with a different sets of primers in oropharyngeal swabs, anal and cervical samples
by: Catia Sias, et al.
Published: (2019-03-01)

Non-invasive Assessment of Vaccine-Induced HPV Antibodies via First-Void Urine
by: Jade Pattyn, et al.
Published: (2020-08-01)

Oral-genital human papillomavirus infection in Polish couples: frequent detection of HPV 42
by: Katarzyna Kiwerska, et al.
Published: (2019-02-01)

Prevalence, incidence, and natural history of HPV infection in adult women ages 24 to 45 participating in a vaccine trial
by: Daron G. Ferris, et al.
Published: (2020-12-01)

Human Papillomavirus (HPV69/HPV73) Coinfection associated with Simultaneous Squamous Cell Carcinoma of the Anus and Presumed Lung Metastasis
by: Stephanie Shea, et al.
Published: (2020-03-01)

Cervicovaginal Microbiome and Urine Metabolome Paired Analysis Reveals Niche Partitioning of the Microbiota in Patients with Human Papilloma Virus Infections
by: Nataliya Chorna, et al.
Published: (2020-01-01)

Changes in Cervical Human Papillomavirus (HPV) Prevalence at a Youth Clinic in Stockholm, Sweden, a Decade After the Introduction of the HPV Vaccine
by: Andreas Ährlund-Richter, et al.
Published: (2019-03-01)

Vaccination against HPV: Theoretical Aspects and Practical Results of Cervical Cancer Prevention
by: N. V. Zarochentseva, et al.
Published: (2020-01-01)

Human Papillomavirus (HPV): unawareness of the causal role of HPV infection in cervical cancer, HPV vaccine availability, and HPV vaccine uptake among female schoolteachers in a Middle Eastern country
by: Juman Rezqalla, et al.
Published: (2021-05-01)

Genital warts trends in Australian and overseas-born people in Australia: A cross-sectional trend analysis to measure progress towards control and elimination
by: Laila Khawar, MPH, et al.
Published: (2021-11-01)

HPV infection in cervical and other cancers in Saudi Arabia: implication for prevention and vaccination
by: Ghazi eAlsbeih
Published: (2014-03-01)

CIN2+ detection of the HPV DNA Array genotyping assay in comparison with the Cobas 4800 HPV test and cytology
by: Aleksandra Pesic, et al.
Published: (2019-07-01)

Alterations of HPV-Related Biomarkers after Prophylactic HPV Vaccination. A Prospective Pilot Observational Study in Greek Women
by: George Valasoulis, et al.
Published: (2020-05-01)

GENITAL AND PERIGENITAL HUMAN PAPILOMAVIRUS (HPV) INFECTION IN SMALL CHILD
by: Carmen Sălăvăstru, et al.
Published: (2009-05-01)

Demographic and Socioeconomic Factors Associated With HPV Vaccination in Georgia’s South Central Health District
by: Sydney Ekeledo, et al.
Published: (2016-04-01)

HPV and Cytology Testing in Women Undergoing 9-Valent HPV Opportunistic Vaccination: A Single-Cohort Follow Up Study
by: Rosa De Vincenzo, et al.
Published: (2021-06-01)

Diez años de vacunación frente al virus del papiloma humano. De la dermatología a la oncología a través de la infectología
by: Fernando A. Moraga-Llop
Published: (2018-05-01)

Human Papillomavirus Infections in Cervical Samples From HIV-Positive Women: Evaluation of the Presence of the Nonavalent HPV Genotypes and Genetic Diversity
by: Catia Sias, et al.
Published: (2020-11-01)

Regular Healthcare Provider Status Does Not Moderate Racial/Ethnic Differences in Human Papillomavirus (HPV) and HPV Vaccine Knowledge
by: Trisha L. Amboree, et al.
Published: (2021-07-01)

Quality assurance of human papillomavirus (HPV) testing in the implementation of HPV primary screening in Norway: an inter-laboratory reproducibility study
by: Birgit Engesæter, et al.
Published: (2016-11-01)

Genetic and Epigenetic Variations of HPV52 in Cervical Precancer
by: Katharine J. Bee, et al.
Published: (2021-06-01)

Methodologies of Primary HPV Testing Currently Applied for Cervical Cancer Screening
by: Andreas C. Chrysostomou, et al.
Published: (2020-11-01)

Defining Elimination of Genital Warts—A Modified Delphi Study
by: Laila Khawar, et al.
Published: (2020-06-01)

Kosovo women’s knowledge and awareness of human papillomavirus (HPV) infection, HPV vaccination, and its relation to cervical cancer
by: Pranvera Zejnullahu Raçi, et al.
Published: (2021-10-01)

A study of type-specific HPV natural history and implications for contemporary cervical cancer screening programs
by: Maria Demarco, et al.
Published: (2020-05-01)